Author

Asmaa O. Mohamed

Dartmouth College

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Synthetic Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Yina H. HuangiD· 2 shared Chanhyuk ParkiD· 1 shared Colin J. Hartman· 1 shared David N. KragiD· 1 shared Fred KollingiD· 1 shared Girja S. ShuklaiD· 1 shared Helen C. JarnaginiD· 1 shared Jason Gunn· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersSynthetic Biology

Yina H. HuangORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Anti-CD206 CAR T Cell Treatment Restores Fibrosis-Induced Loss of Dermal White Adipose Tissue

Chanhyuk Park, Asmaa O. Mohamed, Helen C. Jarnagin, Rajan Bhandari, Jason Gunn, Joana M. Murad-Mabaera, Noelle N. Kosarek, Fred Kolling, Owen Michael Wilkins, Yina H. Huang, Michael L. Whitfield, Patricia Ann Pioli

The paper demonstrates that anti-CD206 CAR T cells restore dermal white adipose tissue in systemic sclerosis by targeting CD206+ macrophages and reversing their effects on adipose-derived stem cells.

bioRxiv · Oct 16, 2025 · PreprintSynthetic Biology

Cancer therapy via neoepitope-specific monoclonal antibody cocktails

Colin J. Hartman, Asmaa O. Mohamed, Girja S. Shukla, Stephanie C. Pero, Yu-Jing Sun, Roberto Rodríguez–Jiménez, Nicholas F. Genovese, N. Köhler, Thomas R. Hemphill, Yina H. Huang, David N. Krag, Margaret E. Ackerman

This paper demonstrates the use of neoepitope-specific monoclonal antibody cocktails to treat B16F10 melanoma by targeting unique tumor mutations, showing in vitro and in vivo efficacy.

Cancer Immunology Immunotherapy · May 31, 2025Peer-reviewedImmunology